Increased Gastrointestinal Distress The most common side effect of GLP-1 medications is nausea
Reported incidences included nausea (5.922.2%), diarrhea (8.825.3%), vomiting (2.99.1%), and constipation (8.816.2%), with discontinuation rates reaching 19% in high-dose monthly regimens (816 mg) [62,63,64]
Additionally, the updated model included covariates on oral absorption parameters estimated in the current analysis, which were: body weight (continuous), post-dose fasting time (15, 30, 60, 120, 240, 300 min) and water volume (50, 120, 240 mL) for F , and post-dose fasting time for k a
Common side effects are mild and temporary such as nausea or reduced appetite which typically improve over time
The high price of treatment raises concerns about worsening health disparities, since obesity already disproportionately affects marginalized racial, ethnic, and socioeconomic groups
Diverse Doses for Personalized Treatment: Fitaro is available in multiple doses, including 1mg, 0.5mg, 2.4mg, 1.7mg, and 0.25mg